Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 436181 - 436200 out of 560178 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Saudi Arabia | (L01XG01) bortezomib | BORTEZOMIB NEAPOLIS | 1 Vial, 3.5 mg, Intravenous, Subcutaneous, powder for solution for injection, 3.5mg , Vial, powder for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | LESLABORATORIESNEAPOLISPHARMA / LESLABORATORIESNEAPOLISPHARMA |
| Saudi Arabia | (L01XG01) bortezomib | BORTEZOMIB SPC 3.5 mg Powder for Solution for Infusion | 1 Vial, 10ml, 3.5 mg, Subcutaneous use, powder for solution for injection, 3.5mg , Vial, powder for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | SUDAIRPHARMACOMPANY / Dr.Reddy’sLaboratoriesLtd.FormulationUnitVII |
| Saudi Arabia | (L01XG01) bortezomib | BORTEZON 3.5 mg Powder For Solution For Injection | 1 Vial, 3.5 mg, Subcutaneous use, powder for solution for injection, 3.5mg , Vial, powder for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | PharmaPharmaceuticalIndustries(PPI) / PHARMASCIENCEINC. |
| Saudi Arabia | (L01XG01) bortezomib | VEELBORE 3.5 mg Powder For Solution For Injection | 1 Vial, 8ml, 3.5 mg, Subcutaneous use, powder for solution for injection, 3.5mg , Vial, powder for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / PharmIdeaSIA |
| Saudi Arabia | (L01XG01) bortezomib | Bortada | 1 Vial, 1,4ml, 2.5 mg, Intravenous, Subcutaneous, Solution for injection, 2.5mg , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | STADAARZNEIMITTELGmbH / THYMOORGANPHARMAZIEGMBH |
| Saudi Arabia | (L01XG01) bortezomib | Bortezomib EPC | 1 Vial, 3.5 mg, Intravenous, Subcutaneous, powder for solution for injection, 3.5mg , Vial, powder for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | EasternPharmaCo(EPC) / RelianceLifeSciencesPvt.Ltd |
| Saudi Arabia | (L01XG01) bortezomib | Borvix | 1 Vial, 10ml, 3.5 mg, Intravenous use, powder for solution for injection, 3.5mg , Vial, powder for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | MSPharmaSaudi(MSPS) / QiluPharmaceuticalHainanCoLtd |
| Saudi Arabia | (L01XG01) bortezomib | IMOZET 3.5MG POWDER FOR SOLUTION FOR INJECTION | 1 Vial, 10ml, 3.5 mg, Intravenous, Subcutaneous, powder for solution for injection, 3.5mg , Vial, powder for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareS.L.U / INTASPHARMACEUTICALSLIMITED |
| Saudi Arabia | (L01XG01) bortezomib | Proteomib | 1 Vial, 3.5 mg, Intravenous, Subcutaneous, powder for solution for injection, 3.5mg , Vial, powder for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | VENUSREMEDIESLIMITED / VENUSREMEDIESLIMITED |
| Saudi Arabia | (L01XL04) tisagenlecleucel | Kymriah | 1 Bag, 1ml, 6 cells, Intravenous use, Dispersion for infusion, 6cells , Bag, Dispersion for infusion | Retail price without vat |
$0-0 |
$0-0 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Large B-Cell, Diffuse | NovartisEuropharmLimited / NOVARTIS |
| Saudi Arabia | (L01XX05) hydroxycarbamide | Cekea | 30 Blister, 500 mg, Oral use, Capsule, hard, 500mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
n/a | SUDAIRPHARMACOMPANY / SudairPharmaCompany |
| Saudi Arabia | (L01XX05) hydroxycarbamide | Cekea | 30 Blister, 200 mg, Oral use, Capsule, hard, 200mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
n/a | SUDAIRPHARMACOMPANY / SudairPharmaCompany |
| Saudi Arabia | (L01XX05) hydroxycarbamide | XROMI | 1 Bottle, 150ml, 100 mg/ml, Oral use, Oral solution, 100mg/ml , Bottle, Oral solution | Retail price without vat |
$0-0 |
$0-0 |
Anemia, Sickle Cell | NovaLaboratoriesLimited / NovaLaboratoriesLtd |
| Saudi Arabia | (L01XX17) topotecan | HYCAMTIN 4MG I.V. VIAL | 1 Vial, 4 mg, Intravenous use, Powder for concentrate for solution for infusion, 4mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Ovarian Neoplasms; Uterine Cervical Neoplasms; Small Cell Lung Carcinoma | SandozPharmaceuticals / GLAXOSMITHKLINEMANUFACTURINGS.P.A. |
| Saudi Arabia | (L01XX19) irinotecan | IRINOTECAN JAZEERA 20 mg/ml concentrate for solution for infusion | 1 Vial, 2ml, 20 mg/ml, Intravenous use, concentrate for solution for injection, 20mg/ml , Vial, concentrate for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / THYMOORGANPHARMAZIEGMBH |
| Saudi Arabia | (L01XX19) irinotecan | IRINOTECAN JAZEERA 20 mg/ml concentrate for solution for infusion | 1 Vial, 5ml, 20 mg/ml, Intravenous use, concentrate for solution for injection, 20mg/ml , Vial, concentrate for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / THYMOORGANPHARMAZIEGMBH |
| Saudi Arabia | (L01XX19) irinotecan | IMTUS 20MG/ML SOL. FOR INFUSION | 1 Vial, 5ml, 20 mg/ml, Intravenous use, Solution for infusion, 20mg/ml , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | EmcurePharmaceuticalsLtd. / EmcurePharmaceuticalsLtd. |
| Saudi Arabia | (L01XX19) irinotecan | IMTUS 20MG/ML SOL. FOR INFUSION | 1 Vial, 2ml, 20 mg/ml, Intravenous use, Solution for infusion, 20mg/ml , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | EmcurePharmaceuticalsLtd. / EmcurePharmaceuticalsLtd. |
| Saudi Arabia | (L01XX24) pegaspargase | Oncaspar | 1 Vial, 1ml, 750 IU/ml, Intramuscular and intravenous use, Powder for solution for injection/infusion, 750IU/ml , Vial, Powder for solution for injection/infusion | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | LESLABORATOIRESSERVIER / LESLABORATOIRESSERVIERINDUSTRIE |
| Saudi Arabia | (L01XX41) eribulin | HALAVEN | 1 Vial, 2ml, 0.44 mg/ml, Intravenous use, Solution for injection, 0.44mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms; Liposarcoma | EISAIEUROPELIMITED / BSPPHARMACEUTICALS |
Pages
